These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20392828)

  • 1. Therapeutic concentrations of mitotane (o,p'-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model.
    Zatelli MC; Gentilin E; Daffara F; Tagliati F; Reimondo G; Carandina G; Ambrosio MR; Terzolo M; Degli Uberti EC
    Endocrinology; 2010 Jun; 151(6):2453-61. PubMed ID: 20392828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitotane treatment in patients with adrenocortical cancer causes central hypothyroidism.
    Russo M; Scollo C; Pellegriti G; Cotta OR; Squatrito S; Frasca F; Cannavò S; Gullo D
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):614-9. PubMed ID: 26221968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function.
    Gentilin E; Tagliati F; Terzolo M; Zoli M; Lapparelli M; Minoia M; Ambrosio MR; Degli Uberti EC; Zatelli MC
    J Endocrinol; 2013 Sep; 218(3):275-85. PubMed ID: 23814013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirement of thyrotropin-releasing hormone for the postnatal functions of pituitary thyrotrophs: ontogeny study of congenital tertiary hypothyroidism in mice.
    Shibusawa N; Yamada M; Hirato J; Monden T; Satoh T; Mori M
    Mol Endocrinol; 2000 Jan; 14(1):137-46. PubMed ID: 10628753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid-stimulating hormone, prolactin, and growth hormone response to thyrotropin-releasing hormone in treated children with congenital hypothyroidism.
    Sack J; Shafrir Y; Urbach D; Amado O
    Pediatr Res; 1985 Oct; 19(10):1037-9. PubMed ID: 3932951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of mitotane on viability and secretory activity in mouse gonadotroph cell lines.
    Gentilin E; Molè D; Gagliano T; Minoia M; Ambrosio MR; Degli Uberti EC; Zatelli MC
    Reprod Toxicol; 2014 Jun; 45():71-6. PubMed ID: 24486453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotropin-releasing hormone and thyrotropin secretion.
    Utiger RD
    J Lab Clin Med; 1987 Mar; 109(3):327-35. PubMed ID: 3102657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperresponse to thyrotropin-releasing hormone accompanying small decreases in serum thyroid hormone concentrations.
    Vagenakis AG; Rapoport B; Azizi F; Portnay GI; Braverman LE; Ingbar SH
    J Clin Invest; 1974 Oct; 54(4):913-8. PubMed ID: 4214837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum concentrations of thyroxine, 3,5,3'-triiodothyronine, thyrotropin, and prolactin in dogs before and after thyrotropin-releasing hormone administration.
    Kaufman J; Olson PN; Reimers TJ; Allen TA; Soderberg SF; Nett TM; Wheeler SL; Wingfield WE
    Am J Vet Res; 1985 Feb; 46(2):486-92. PubMed ID: 3922262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of hypothyroidism and hypoprolactinemia by growth hormone producing rat pituitary tumors.
    Seo H; Refetoff S; Fang VS
    Endocrinology; 1977 Jan; 100(1):216-26. PubMed ID: 401484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of thyrotropin (TSH) release and production in monolayer cultures of transplantable TSH-producing mouse tumors.
    Eto S; Fleischer N
    Endocrinology; 1976 Jan; 98(1):114-22. PubMed ID: 174885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of thyrotropin responses to thyrotropin-releasing hormone following small decreases in serum thyroid hormone concentrations.
    Saberi M; Utiger RD
    J Clin Endocrinol Metab; 1975 Mar; 40(3):435-41. PubMed ID: 803974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPARα modulates the TSH β-subunit mRNA expression in thyrotrope TαT1 cells and in a mouse model.
    Wege N; Schutkowski A; König B; Brandsch C; Weiwad M; Stangl GI
    Mol Nutr Food Res; 2013 Mar; 57(3):376-89. PubMed ID: 23255496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyrotropin expression in hypophyseal pars tuberalis-specific cells is 3,5,3'-triiodothyronine, thyrotropin-releasing hormone, and pit-1 independent.
    Bockmann J; Böckers TM; Winter C; Wittkowski W; Winterhoff H; Deufel T; Kreutz MR
    Endocrinology; 1997 Mar; 138(3):1019-28. PubMed ID: 9048604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased sensitivity of the thyrotroph to thyrotropin-releasing hormones in rats with hypothalamic hypothyroidism.
    Aizawa T; Kobayashi M; Komiya I; Hiramatsu K; Sato A; Yamada T
    Endocrinology; 1984 Jan; 114(1):8-13. PubMed ID: 6418526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable thyrotropin response to thyrotropin-releasing hormone after small decreases in plasma free thyroid hormone concentrations in patients with nonthyroidal diseases.
    Maturlo SJ; Rosenbaum RL; Pan C; Surks MI
    J Clin Invest; 1980 Sep; 66(3):451-6. PubMed ID: 6772675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response.
    Snyder PJ; Utiger RD
    J Clin Invest; 1973 Sep; 52(9):2305-12. PubMed ID: 4199417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained rises in serum thyrotropin, thyroxine, and triiodothyronine during long term, continuous thyrotropin-releasing hormone treatment in patients with amyotrophic lateral sclerosis.
    Kaplan MM; Taft JA; Reichlin S; Munsat TL
    J Clin Endocrinol Metab; 1986 Oct; 63(4):808-14. PubMed ID: 3091628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotropin-releasing hormone and thyroid hormone interactions on thyrotropin secretion in the rat: lack of inhibiting effects of small doses of triiodo-L-thyronine in the hypothyroid rat.
    García MD; Escobar del Rey F; Morreale de Escobar G
    Endocrinology; 1976 Jan; 98(1):203-13. PubMed ID: 813987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitotane has an estrogenic effect on sex hormone-binding globulin and corticosteroid-binding globulin in humans.
    Nader N; Raverot G; Emptoz-Bonneton A; Déchaud H; Bonnay M; Baudin E; Pugeat M
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2165-70. PubMed ID: 16551731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.